Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
<< Back to Introduction to contrast chapter
Prior to activation, LUMINITY appears as a colour less liquid. LUMINITY needs to be ‘activated’ prior to use and this is achieved using a specific Vialmix™ device provided by the company when LUMINITY is ordered.
The Vialmix™ has a pre-defined shaking/agitation time of 45 seconds and rate of agitation, which cannot be altered. At the end of these 45 seconds, the perflutren microspheres have been created and the agent is ready for use.
© 2017 European Society of Cardiology. All rights reserved